Ursapharm Arzneimittel GmbH   Report issue

For profit Phase 4
Founded: Saarbrücken Germany (1974)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2009
NCT01357538
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now